InvestorsHub Logo
Followers 27
Posts 1791
Boards Moderated 0
Alias Born 10/17/2010

Re: rustydog62 post# 9365

Thursday, 07/28/2022 3:30:29 AM

Thursday, July 28, 2022 3:30:29 AM

Post# of 9558
Another good collaboration with IBX, (Patrys Limited Quarterly Report put out today)...


During the quarter, Patrys expanded its research collaboration with Imagion Biosystems (ASX: IBX). In
May 2021 we first reported initiation of our collaboration with Imagion to explore combination of
Imagion’s MagSense® technology and Patrys’ DNA-targeting PAT-DX1 to develop a highly effective
imaging agent with high specificity for hard-to-diagnose cancers such as brain cancer. Both companies
have recently engaged The University of Sydney to further explore the utility of our combined
technologies as a diagnostic imaging marker in a patient derived animal model of Glioblastoma
Multiforme. We expect to report on the progress of these studies in 2023.